Development of NIRS method for quality control of drug combination artesunate-azithromycin for the treatment of severe malaria

被引:9
|
作者
Boyer, Chantal [1 ]
Gaudin, Karen [1 ]
Kauss, Tina [1 ]
Gaubert, Alexandra [1 ]
Boudis, Abdelhakim [1 ]
Verschelden, Justine [1 ]
Franc, Mickael [1 ]
Roussille, Julie [1 ]
Boucher, Jacques [1 ]
Olliaro, Piero [2 ,3 ,4 ]
White, Nicholas J. [3 ,4 ]
Millet, Pascal [1 ]
Dubost, Jean-Pierre [1 ]
机构
[1] Univ Bordeaux Segalen, EA 4575, F-33076 Bordeaux, France
[2] World Hlth Org, Trop Dis Res, Geneva, Switzerland
[3] Mahidol Univ, Bangkok 10400, Thailand
[4] Univ Oxford, Oxford OX1 2JD, England
基金
英国惠康基金;
关键词
Artesunate; Azithromycin; NIRS; Green chemistry; Chemometrics; NEAR-INFRARED SPECTROSCOPY; REVERSED-PHASE HPLC; ANTIMALARIAL ACTIVITY; PHARMACEUTICAL PELLETS; PLASMODIUM-FALCIPARUM; IN-VITRO; VALIDATION; TABLETS; SPECTRA;
D O I
10.1016/j.jpba.2012.04.009
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Near infrared spectroscopy (NIRS) methods were developed for the determination of analytical content of an antimalarial-antibiotic (artesunate and azithromycin) co-formulation in hard gelatin capsule (HGC). The NIRS consists of pre-processing treatment of spectra (raw spectra and first-derivation of two spectral zones), a unique principal component analysis model to ensure the specificity and then two partial least-squares regression models for the determination content of each active pharmaceutical ingredient. The NIRS methods were developed and validated with no reference method, since the manufacturing process of HGC is basically mixed excipients with active pharmaceutical ingredients. The accuracy profiles showed beta-expectation tolerance limits within the acceptance limits (+/- 5%). The analytical control approach performed by reversed phase (HPLC) required two different methods involving two different preparation and chromatographic methods. NIRS offers advantages in terms of lower costs of equipment and procedures, time saving, environmentally friendly. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:10 / 15
页数:6
相关论文
共 10 条
  • [1] Investigation of porous graphitic carbon at high-temperature liquid chromatography with evaporative light scattering detection for the analysis of the drug combination artesunate-Azithromycin for the treatment of severe malaria
    Gaudin, Karen
    Millet, Pascal
    Fawaz, Fawaz
    Olliaro, Piero
    White, Nicholas J.
    Cassus-Coussere, Celine
    Agbahoungha, Ulrich
    Dubost, Jean-Pierre
    JOURNAL OF CHROMATOGRAPHY A, 2010, 1217 (01) : 75 - 81
  • [2] In Vivo Efficacy and Tolerability of Artesunate-Azithromycin for the Treatment of Falciparum Malaria in Vietnam
    Nguyen Chinh Phong
    Huynh Hong Quang
    Nguyen Xuan Thanh
    Trieu Nguyen Trung
    Dai, Bui
    Shanks, G. Dennis
    Chavchich, Marina
    Edstein, Michael D.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (01) : 164 - 167
  • [3] Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria
    Li, Qigui
    Weina, Peter
    PHARMACEUTICALS, 2010, 3 (07): : 2322 - 2332
  • [4] Artesunate monotherapy versus artesunate plus quinine combination therapy for treatment of imported severe malaria: a TropNet retrospective cohort study
    Botta, Annarita
    Comelli, Agnese
    Vellere, Iacopo
    Chechi, Flavia
    Bianchi, Leila
    Giulia, Gardini
    Tomasoni, Lina Rachele
    Spinicci, Michele
    Galli, Luisa
    Castelli, Francesco
    Bartoloni, Alessandro
    Zammarchi, Lorenzo
    INFECTION, 2022, 50 (04) : 949 - 958
  • [5] Artesunate monotherapy versus artesunate plus quinine combination therapy for treatment of imported severe malaria: a TropNet retrospective cohort study
    Annarita Botta
    Agnese Comelli
    Iacopo Vellere
    Flavia Chechi
    Leila Bianchi
    Gardini Giulia
    Lina Rachele Tomasoni
    Michele Spinicci
    Luisa Galli
    Francesco Castelli
    Alessandro Bartoloni
    Lorenzo Zammarchi
    Infection, 2022, 50 : 949 - 958
  • [6] Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use Under an Investigational New Drug Protocol
    Twomey, Patrick S.
    Smith, Bryan L.
    McDermott, Cathy
    Novitt-Moreno, Anne
    McCarthy, William
    Kachur, S. Patrick
    Arguin, Paul M.
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (07) : 498 - +
  • [7] Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial
    Byakika-Kibwika, Pauline
    Achan, Jane
    Lamorde, Mohammed
    Karera-Gonahasa, Carine
    Kiragga, Agnes N.
    Mayanja-Kizza, Harriet
    Kiwanuka, Noah
    Nsobya, Sam
    Talisuna, Ambrose O.
    Merry, Concepta
    BMC INFECTIOUS DISEASES, 2017, 17
  • [8] Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial
    Pauline Byakika-Kibwika
    Jane Achan
    Mohammed Lamorde
    Carine Karera-Gonahasa
    Agnes N. Kiragga
    Harriet Mayanja-Kizza
    Noah Kiwanuka
    Sam Nsobya
    Ambrose O. Talisuna
    Concepta Merry
    BMC Infectious Diseases, 17
  • [9] Development and validation of a HPLC method for a dissolution test of lamotrigine tablets and its application to drug quality control studies
    Sripalakit, Pattana
    Srichaiya, Arunee
    Kandee, Ratchanok
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2008, 31 (06) : 926 - 939
  • [10] Simultaneous Determination of Artesunate and Amodiaquine in Fixed-Dose Combination by a RP-HPLC Method with Double UV Detection: Implementation in Interlaboratory Study Involving Seven African National Quality Control Laboratories
    Le Vaillant, Y.
    Brenier, C.
    Grange, Y.
    Nicolas, A.
    Bonnet, P. A.
    Massing-Bias, L. R.
    Rakotomanga, P.
    Koumare, B.
    Mahly, A.
    Absi, M.
    Ciss, M.
    Loueslati, M. H.
    Chauvey, D.
    CHROMATOGRAPHIA, 2012, 75 (11-12) : 617 - 628